Back to Search
Start Over
Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis
- Source :
- European heart journal. 42(28)
- Publication Year :
- 2021
- Subjects :
- medicine.medical_specialty
Charybdis
biology
business.industry
medicine.drug_class
MEDLINE
Anti-Inflammatory Agents
Myocardial Ischemia
Coronary Artery Disease
medicine.disease
biology.organism_classification
Anti-inflammatory
Coronary artery disease
Residual risk
Pharmaceutical Preparations
Internal medicine
Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARE
medicine
Humans
Ischaemic heart disease
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 15229645
- Volume :
- 42
- Issue :
- 28
- Database :
- OpenAIRE
- Journal :
- European heart journal
- Accession number :
- edsair.doi.dedup.....67e43687ee6d294aac61627ddf2fe5ac